Elucidation of Immunoglobulin Class Switch Recombination
免疫球蛋白类别转换重组的阐明
基本信息
- 批准号:9172233
- 负责人:
- 金额:$ 43.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2019-10-31
- 项目状态:已结题
- 来源:
- 关键词:Alpha CellAntibodiesB-Cell LymphomasB-LymphocytesBase Excision RepairsBindingBiological ModelsCell DeathCellsChromosomal translocationCouplingCyclic AMP-Dependent Protein KinasesDNADNA DamageDNA Double Strand BreakDNA RepairDNA Repair PathwayDataDeaminaseDeaminationDefectDeoxycytidineDeoxyuridineDouble EffectDouble Strand Break RepairElementsEndonuclease IEnsureExcisionExonsFailureFeedbackG1 PhaseGenerationsGenetic RecombinationGrowthHumanIgEImmune responseImmunoglobulin AImmunoglobulin Class SwitchingImmunoglobulin Constant RegionImmunoglobulin GImmunoglobulin MImmunoglobulin Switch RecombinationImmunologic Deficiency SyndromesImpairmentIn VitroIntuitionInvadedLeadLesionLymphomaLymphomagenesisMature B-LymphocyteMediatingMismatch RepairModelingMolecularOrganismPathway interactionsPhosphorylationPlayProcessProteinsReactionRecruitment ActivityRepetitive SequenceRoleSerineSingle-Stranded DNASiteSystemTestingUracilactivation-induced cytidine deaminasearmbasecancer typeconstant region genedensityendodeoxyribonuclease SceIendonucleasein vivoinsightmutantnovelpathogenphosphodiesterpublic health relevancerepair enzymerepairedresponsesensorsingle moleculeuracil-DNA glycosylase
项目摘要
DESCRIPTION (provided by applicant): Mature B-lymphocytes undergo class switch recombination (CSR), a deletional-recombination reaction that replaces the constant region of the immunoglobulin (Ig) molecule for one of a set of downstream constant region genes. This changes the class of the expressed antibody from IgM to IgG, IgE or IgA, each of which has distinct effector functions. CSR occurs within and requires large repetitive sequences termed switch (S) regions that precede the constant region genes. CSR is initiated by AID (activation induced deaminase), a single-strand DNA-specific deaminase, that introduces U:G mismatches in transcribed S regions. Subsequent processing by components of base excision repair and mismatch repair pathways introduces DNA double- stranded breaks (DSBs) in S regions. DSBs between two distinct S regions are synapsed and then ligated by end-joining. DSBs serve as obligatory intermediates of CSR; however, DSBs also constitute one of the most toxic lesions that can occur in a cell. A single unrepaired DSB can lead to cell death or can participate in chromosomal translocations, the hallmarks of many types of cancer, including lymphomas. Thus, CSR requires not only the generation but also efficient repair of DSBs. In this proposal we test the hypothesis that phosphorylation of AID plays an essential role in the generation of DSBs. We also explore the hypothesis that the DNA damage sensor ATM participates in inducing AID phosphorylation and repair of DSBs during the process. Impaired CSR leads to impaired ability to respond to pathogens while aberrant CSR is one of the major underlying factors in the ontogeny of B cell lymphomas. Our studies will thus have major impact on both immunodeficiency syndromes and B cell lymphomagenesis.
描述(由申请人提供):成熟b淋巴细胞进行类开关重组(CSR),这是一种缺失重组反应,将免疫球蛋白(Ig)分子的恒定区替换为一组下游恒定区基因之一。这将表达的抗体类别从IgM改变为IgG、IgE或IgA,每种抗体都具有不同的效应功能。CSR发生在恒定区基因之前的称为开关(S)区域的大型重复序列中。CSR是由AID(激活诱导脱氨酶)启动的,AID是一种单链dna特异性脱氨酶,在转录的S区引入U:G错配。碱基切除修复和错配修复途径的后续处理在S区引入了DNA双链断裂(dsb)。两个不同的S区之间的dsb突触,然后通过末端连接连接。争端解决机构是企业社会责任的强制性中介机构;然而,dsb也是细胞中毒性最强的病变之一。单个未修复的DSB可导致细胞死亡或参与染色体易位,染色体易位是包括淋巴瘤在内的许多类型癌症的标志。因此,CSR不仅需要生成dsb,还需要有效修复dsb。在这个提议中,我们检验了AID的磷酸化在dsb的产生中起重要作用的假设。我们还探讨了DNA损伤传感器ATM参与诱导AID磷酸化和dsb修复的假设。CSR受损导致对病原体的反应能力受损,而CSR异常是B细胞淋巴瘤发生的主要潜在因素之一。因此,我们的研究将对免疫缺陷综合征和B细胞淋巴瘤产生重大影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayanta Chaudhuri其他文献
Jayanta Chaudhuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayanta Chaudhuri', 18)}}的其他基金
RNA-directed targeting of AID in immunity and genomic integrity
RNA 引导的 AID 免疫和基因组完整性靶向
- 批准号:
9095773 - 财政年份:2016
- 资助金额:
$ 43.98万 - 项目类别:
RNA-directed targeting of AID in immunity and cancer
RNA定向靶向AID在免疫和癌症中的作用
- 批准号:
10530805 - 财政年份:2016
- 资助金额:
$ 43.98万 - 项目类别:
RNA-directed targeting of AID in immunity and genomic integrity
RNA 引导的 AID 免疫和基因组完整性靶向
- 批准号:
9210606 - 财政年份:2016
- 资助金额:
$ 43.98万 - 项目类别:
RNA-directed targeting of AID in immunity and cancer
RNA定向靶向AID在免疫和癌症中的作用
- 批准号:
10664029 - 财政年份:2016
- 资助金额:
$ 43.98万 - 项目类别:
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation
类别转换重组和体细胞超突变的机制阐明
- 批准号:
10230368 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
7585561 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
8500117 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
7870360 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
8099602 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation
类别转换重组和体细胞超突变的机制阐明
- 批准号:
10348783 - 财政年份:2009
- 资助金额:
$ 43.98万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 43.98万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 43.98万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 43.98万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 43.98万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 43.98万 - 项目类别: